Nike nearly doubled its revenue year-over-year and says there's even more growth to come - MarketWatch
Nike Inc. Cl B stock rises Friday, outperforms market - MarketWatch
Nike's online sales jumped 31% after company unveiled Kaepernick campaign, data show - MarketWatch
The basketball shoe industry is being crushed by the athleisure wave - MarketWatch
Nike has 10 challenges to overcome, including competition -- not to mention end of Kobe Bryant contract - MarketWatch
Nike sales growth slows amid supply issues, and the stock is falling - MarketWatch
Nike to test Jordan-only stores in North America - MarketWatch
Nike fears customers will move 'towards New Balance' amid SNKRS issues - MarketWatch
Nike earnings withstand production issues and slump in China sales, stock gains - MarketWatch
Nike shares rise on earnings, DuPont falls on outlook - MarketWatch
Nike upgraded in face of Colin Kaepernick advertising controversy - MarketWatch
Nike's quarterly profit beats Wall Street expectations, $18 billion buyback approved - MarketWatch
Nike shares tumble after conservative outlook, but analysts say 'don't be fooled' - MarketWatch
What to expect from Nike earnings - MarketWatch
Nike stock rallies as sales surpass Street estimates by more than $1 billion - MarketWatch
Nike earnings: Adidas supply-chain shortage will benefit Nike - MarketWatch
Nike preview: Momentum is growing, but is it enough to reach $50 billion sales goal? - MarketWatch
Nike earnings preview: Why analysts are trimming profit forecasts - MarketWatch
Trump suggests that Nike's stock is 'getting absolutely killed with anger and boycotts' - MarketWatch
Nike earnings could be squeezed by competition - MarketWatch
Nike investors won't force company to show results of diversity efforts - MarketWatch
Nike earnings preview: Executive changes show long-term goals are still in focus - MarketWatch
Nike earnings: Tariffs aren't a threat to the athletic giant - MarketWatch
Nike's Q2 profit rises 32% - MarketWatch
Nike is suffering as Adidas and Under Armour gain momentum - MarketWatch
